SPDR S&P Biotech ETF

Yield per half year: -12.17%
Industry: Health & Biotech Equities

Exact Sciences Corporation
United Therapeutics Corporation
Gilead Sciences
AbbVie
Viking Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc.
Regeneron
Amgen
BioMarin Pharmaceutical
Sarepta Therapeutics, Inc.
Other
Exact Sciences Corporation: 3.7%United Therapeutics Corporation: 3.2%Gilead Sciences: 3%AbbVie: 2.9%Viking Therapeutics, Inc.: 2.9%Alnylam Pharmaceuticals, Inc.: 2.9%Regeneron: 2.9%Amgen: 2.8%Other: 70.3%Share share by companyen.porti.ru
Download SVG
Download PNG
Download CSV
TitleIndustryShare, %P/BVP/SP/EEV/EbitdaDividend yield
Exact Sciences Corporation Exact Sciences Corporation Healthcare 3.69241 4.21 5.3 0 -1156.76 0
United Therapeutics Corporation United Therapeutics Corporation Healthcare 3.16376 1.82 4.67 11.05 7.48 0
Gilead Sciences Gilead Sciences Healthcare 3.0438 4.41 3.7 17.69 15.66 3.69
AbbVie AbbVie Healthcare 2.91901 26.42 5.06 56.49 17.75 3.31
Viking Therapeutics, Inc. Viking Therapeutics, Inc. Healthcare 2.90984 5.14 0 0 -17.24 0
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Healthcare 2.8816 -108.14 13.05 0 -112.79 0
Regeneron Regeneron Healthcare 2.86512 3.71 7.34 24.35 23.78 0.1388
Amgen Amgen Healthcare 2.80227 24.53 5.42 22.76 26.16 2.92
BioMarin Pharmaceutical BioMarin Pharmaceutical Healthcare 2.73778 3.72 4.51 30.16 71.81 0
Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. Healthcare 2.64882 10.17 6.87 55.57 -36.23 0
29.66-2.45.5921.81-116.041.01

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription